Skip to main content

4TEEN4 Pharmaceuticals

Hennigsdorf, Germany

4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment of Circulatory Shock.

$35.9M raised
Nov 2025
Series C

Top Investors

NRW.BANKFLORA VenturesBrandenburg KapitalTherabelToucan Health Innovations

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about 4TEEN4 Pharmaceuticals

How much funding has 4TEEN4 Pharmaceuticals raised?
4TEEN4 Pharmaceuticals has raised $35.9M in total funding. The most recent round was Series C. The last funding was announced in November 2025.
Who are 4TEEN4 Pharmaceuticals's investors?
4TEEN4 Pharmaceuticals's investors include NRW.BANK, FLORA Ventures, Brandenburg Kapital, Therabel, Toucan Health Innovations.
Where is 4TEEN4 Pharmaceuticals headquartered?
4TEEN4 Pharmaceuticals is headquartered in Hennigsdorf, Germany.
What does 4TEEN4 Pharmaceuticals do?
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment of Circulatory Shock.
What stage is 4TEEN4 Pharmaceuticals at?
4TEEN4 Pharmaceuticals is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"4TEEN4 Pharmaceuticals — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/4teen4-pharmaceuticals. Accessed June 17, 2026.
APA
VCBacked. (2025). 4TEEN4 Pharmaceuticals — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/4teen4-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=4TEEN4 Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/4teen4-pharmaceuticals |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .